ReShape Lifesciences Inc. (NASDAQ:RSLS – Get Free Report) was the recipient of a significant increase in short interest in July. As of July 15th, there was short interest totalling 1,720,000 shares, an increase of 272.0% from the June 30th total of 462,400 shares. Based on an average daily trading volume, of 6,270,000 shares, the days-to-cover ratio is currently 0.3 days. Currently, 6.6% of the shares of the stock are sold short.
Wall Street Analyst Weigh In
Separately, Maxim Group reaffirmed a “hold” rating on shares of ReShape Lifesciences in a research note on Wednesday, July 17th.
View Our Latest Report on ReShape Lifesciences
ReShape Lifesciences Trading Up 3.7 %
ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) last announced its earnings results on Wednesday, May 15th. The medical device company reported ($0.09) earnings per share for the quarter. The company had revenue of $1.94 million during the quarter. ReShape Lifesciences had a negative net margin of 130.99% and a negative return on equity of 207.78%.
ReShape Lifesciences Company Profile
ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.
Recommended Stories
- Five stocks we like better than ReShape Lifesciences
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- The How and Why of Investing in Gold Stocks
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- What are earnings reports?
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for ReShape Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReShape Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.